Syngen Biotech (8279) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 生展

Syngen Biotech (8279) reported revenue of NT$193.4 million for Oct 2026, +12.3% year on year and -4.0% from the previous month. Revenue for Jan–Oct 2026 was NT$1.76 billion (-3.7% year on year).

In Oct 2026, it ranked No. 43 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$150 million24/10Nov 2024 NT$170 millionDec 2024 NT$154.7 millionJan 2025 NT$121.4 millionFeb 2025 NT$167.9 million25/02Mar 2025 NT$196.6 millionApr 2025 NT$236.4 millionMay 2025 NT$204.6 millionJun 2025 NT$166.6 million25/06Jul 2025 NT$167 millionAug 2025 NT$177.7 millionSep 2025 NT$218.5 millionOct 2025 NT$172.2 million25/10Nov 2025 NT$139.9 millionDec 2025 NT$167.7 millionJan 2026 NT$129.5 millionFeb 2026 NT$138.1 million26/02Mar 2026 NT$149.1 millionApr 2026 NT$234.4 millionMay 2026 NT$182.5 millionJun 2026 NT$176.6 million26/06Jul 2026 NT$178.1 millionAug 2026 NT$178.7 millionSep 2026 NT$201.4 millionOct 2026 NT$193.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$193.4 million+12.3%-4.0%
Sep 2026NT$201.4 million-7.8%+12.7%
Aug 2026NT$178.7 million+0.6%+0.4%
Jul 2026NT$178.1 million+6.6%+0.8%
Jun 2026NT$176.6 million+6.0%-3.2%
May 2026NT$182.5 million-10.8%-22.1%
Apr 2026NT$234.4 million-0.8%+57.2%
Mar 2026NT$149.1 million-24.2%+8.0%
Feb 2026NT$138.1 million-17.7%+6.7%
Jan 2026NT$129.5 million+6.6%-22.8%
Dec 2025NT$167.7 million+8.3%+19.8%
Nov 2025NT$139.9 million-17.7%-18.7%
Oct 2025NT$172.2 million+14.8%-21.2%
Sep 2025NT$218.5 million+17.5%+23.0%
Aug 2025NT$177.7 million-9.4%+6.4%
Jul 2025NT$167 million-3.8%+0.2%
Jun 2025NT$166.6 million+7.8%-18.6%
May 2025NT$204.6 million+14.6%-13.4%
Apr 2025NT$236.4 million+29.4%+20.2%
Mar 2025NT$196.6 million+24.0%+17.1%
Feb 2025NT$167.9 million+11.9%+38.3%
Jan 2025NT$121.4 million-23.7%-21.5%
Dec 2024NT$154.7 million-0.1%-9.0%
Nov 2024NT$170 million+9.4%+13.3%
Oct 2024NT$150 million-0.9%-19.3%

Jan–Oct 2026 cumulative: NT$1.76 billion (-3.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Syngen Biotech vs PEC / Syngen Biotech vs Lotus Pharm / Syngen Biotech vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16